LN5P45
LN5P45 is an OTUB2 inhibitor (IC50: 2.3 μM) . LN5P45 induces monoubiquitination of OTUB2 on lysine 31. LN5P45 can be used for research of tumor progression and metastasis[1].
Product Specifications
UNSPSC
12352005
Target
Cathepsin
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ln5p45.html
Concentration
10mM
Purity
99.05
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC=CC([C@H]2C[C@@H]2C(NNC(CCl)=O)=O)=C1
Molecular Formula
C13H15ClN2O2
Molecular Weight
266.72
References & Citations
[1]Gan J, et al. Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2. ACS Chem Biol. 2023 Aug 29.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1366047-01 0.02 mg (E-Coli)
Recombinant Mycoplasma pulmonis SsrA-binding protein (smpB)
Ask
View Details